Source: Thomson Reuters, August 5, 2019
Innovative Medicines Canada asks federal government to use ‘tools’ to stop bulk exports
Canada’s main pharmaceutical lobby group has urged the government not to wait for drug shortages before responding to U.S. plans to import Canadian drugs, according to documents seen by Reuters.
The talking points were prepared last month by Innovative Medicines Canada (IMC) for its staff and member companies, before the Trump administration announced on Wednesday that it would allow U.S. states and other groups to start pilot programs importing cheap drugs from Canada in an effort to lower drug costs.
For the latest information and for more updates on everything Kindersley ‘Like’ the Kindersley Social Facebook page below…
